Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 11
Submit an article Journal homepage
125
Views
74
CrossRef citations to date
0
Altmetric
Research Article

Anti-CD20 Therapy for Chronic Lymphocytic Leukemia-associated Autoimmune Diseases

Francesco Zaja Clinica Ematologica. Policlinico Universilario, P. zza S. M. Misericordia, 33100 Udine, Italy
,
Nicola Vianelli Istituto di Ematologia ed Oncologia Medica L.e A. Seragnoli, Bologna, Italy
,
Alessandra Sperotto Clinica Ematologica. Policlinico Universilario, P. zza S. M. Misericordia, 33100 Udine, Italy
,
Francesca Patriarca Clinica Ematologica. Policlinico Universilario, P. zza S. M. Misericordia, 33100 Udine, Italy
,
Monica Tani Istituto di Ematologia ed Oncologia Medica L.e A. Seragnoli, Bologna, Italy
,
Luciana Marin Clinica Ematologica. Policlinico Universilario, P. zza S. M. Misericordia, 33100 Udine, Italy
,
Mario Tiribelli Clinica Ematologica. Policlinico Universilario, P. zza S. M. Misericordia, 33100 Udine, Italy
,
Anna Candoni Clinica Ematologica. Policlinico Universilario, P. zza S. M. Misericordia, 33100 Udine, Italy
,
Michele Baccarani Istituto di Ematologia ed Oncologia Medica L.e A. Seragnoli, Bologna, Italy
&
Renato Fanin Clinica Ematologica. Policlinico Universilario, P. zza S. M. Misericordia, 33100 Udine, Italy
 show all
Pages 1951-1955 | Published online: 22 Nov 2010

Citations (74)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Wilma Barcellini & Bruno Fattizzo. (2018) Autoimmune hemolytic anemia - progress in emerging treatment options. Expert Opinion on Orphan Drugs 6:4, pages 273-282.
Read now
Preetesh Jain & Susan O'Brien. (2013) Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia. Expert Opinion on Biological Therapy 13:2, pages 169-182.
Read now
Tadeusz Robak. (2012) Rituximab for chronic lymphocytic leukemia. Expert Opinion on Biological Therapy 12:4, pages 503-515.
Read now
Matthew Kaufman, Sewanti A. Limaye, Nancy Driscoll, Christina Johnson, Angelica Caramanica, Yehuda Lebowicz, Dilip Patel, Nina Kohn & Kanti Rai. (2009) A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia. Leukemia & Lymphoma 50:6, pages 892-899.
Read now
Pascal Sève, Pierre Philippe, Jean-François Dufour, Christiane Broussolle & Marc Michel. (2008) Autoimmune hemolytic anemia: classification and therapeutic approaches. Expert Review of Hematology 1:2, pages 189-204.
Read now
Giovanni D'Arena$suffix/text()$suffix/text() & Nicola Cascavilla. (2007) Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Leukemia & Lymphoma 48:6, pages 1072-1080.
Read now
Lev Shvidel, Mordechai Shtalrid & Alain Berrebi. (2004) Intractable Autoimmune Hemolytic Anemia in B Cell Chronic Lymphocytic Leukemia Resolved by Rituximab. Leukemia & Lymphoma 45:7, pages 1493-1494.
Read now

Articles from other publishers (67)

Muhammed Talha Bilgihan, Ayse Nur Eryigit & Rafiye Ciftciler. (2023) Efficacy and Safety of Immune Checkpoint Inhibitors in Hematologic Malignancies. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Purva Sharma, Rani Sawtell, Qiyu Wang & Meghan E. Sise. (2023) Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease. Advances in Kidney Disease and Health 30:4, pages 343-355.
Crossref
Mohammad Ammad Ud Din, Amir Mahmud, Mariam Mostafa, Moazzam Shahzad, Hania Liaqat, Javier Pinilla-Ibarz & Michael Jaglal. (2023) Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database. Annals of Hematology 102:4, pages 889-895.
Crossref
Meghan E. Sise. (2022) Glomerular Disease in Patients with Acute and Chronic Infections. Nephrology Self-Assessment Program 21:5, pages 383-393.
Crossref
Qiulian He, Peng Ma & Ramin Torshizi. (2022) The Impact of Some Natural Phenolic Compounds on α-Glucosidase and Sorbitol Dehydrogenase Enzymes, and Anti-leukemia Cancer Potential, Spin Density Distributions, and <i>in silico</i> Studies. Journal of Oleo Science 71:6, pages 863-873.
Crossref
Nil Albiol & Carol Moreno. (2021) Autoimmune Cytopenia in CLL. The Cancer Journal 27:4, pages 286-296.
Crossref
Meghan E. Sise. (2020) Glomerular Disease in Patients with Acute and Chronic Infections. Nephrology Self-Assessment Program 19:2, pages 99-109.
Crossref
Aviwe Ntsethe, Phiwayinkosi Vusi Dludla, Tawanda Maurice Nyambuya, Siphamandla Raphael Ngcobo & Bongani Brian Nkambule. (2020) The impact of immune checkpoint inhibitors in patients with chronic lymphocytic leukemia (CLL). Medicine 99:28, pages e21167.
Crossref
Carol Moreno, Carolina Cuellar & Eva Puy Vicente. 2019. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 123 136 .
Joshua D. Long, Stephanie M. Rutledge & Meghan E. Sise. (2018) Autoimmune Kidney Diseases Associated with Chronic Viral Infections. Rheumatic Disease Clinics of North America 44:4, pages 675-698.
Crossref
Michael HallekBruce D. ChesonDaniel CatovskyFederico Caligaris-CappioGuillermo DighieroHartmut DöhnerPeter HillmenMichael KeatingEmili MontserratNicholas ChiorazziStephan StilgenbauerKanti R. RaiJohn C. ByrdBarbara EichhorstSusan O’BrienTadeusz RobakJohn F. Seymour & Thomas J. Kipps. (2018) iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 131:25, pages 2745-2760.
Crossref
Stephanie M. Rutledge, Raymond T. Chung & Meghan E. Sise. (2018) Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis. Hemodialysis International 22:S1.
Crossref
Kerry A. Rogers & Jennifer A. Woyach. (2016) Secondary autoimmune cytopenias in chronic lymphocytic leukemia. Seminars in Oncology 43:2, pages 300-310.
Crossref
Quitterie Reynaud, Isabelle Durieu, Marine Dutertre, Stanislas Ledochowski, Stéphane Durupt, Anne-Sophie Michallet, Denis Vital-Durand & Jean-Christophe Lega. (2015) Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies. Autoimmunity Reviews 14:4, pages 304-313.
Crossref
Howard A. Liebman. (2014) Thrombocytopenia in cancer patients. Thrombosis Research 133, pages S63-S69.
Crossref
José Carlos Jaime-Pérez, Marisol Rodríguez-Martínez, Andrés Gómez-de-León, Luz Tarín-Arzaga & David Gómez-Almaguer. (2013) Current Approaches for the Treatment of Autoimmune Hemolytic Anemia. Archivum Immunologiae et Therapiae Experimentalis 61:5, pages 385-395.
Crossref
Irit Avivi, Dina Stroopinsky & Tamar Katz. (2013) Anti-CD20 monoclonal antibodies: Beyond B-cells. Blood Reviews 27:5, pages 217-223.
Crossref
Moshe E. Gatt, Dina Ben-Yehuda & Shai Izraeli. 2013. Clinical Immunology. Clinical Immunology 946 961 .
Gautam Borthakur & Susan O’Brien. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 103 119 .
Jasper M. Morrow, Shirley D’Sa, Rupert A. Page, Mahir Al Hilali, Michael P. Lunn & Mary M. Reilly. (2011) Rituximab responsive multiple radiculopathies and cranial nerve palsies in association with chronic lymphocytic leukaemia. Journal of Neurology 259:3, pages 571-573.
Crossref
Wilma Barcellini & Alberto Zanella. (2011) Rituximab therapy for autoimmune haematological diseases. European Journal of Internal Medicine 22:3, pages 220-229.
Crossref
Daan Dierickx, André Delannoy, Khalid Saja, Gregor Verhoef & Drew Provan. (2011) Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders. American Journal of Hematology 86:3, pages 278-291.
Crossref
Giovanni D’Arena, Silvana Capalbo, Luca Laurenti, Giovanni Del Poeta, Giuseppe Nunziata, Silvia Deaglio, Giuseppina Spinosa, Michela Tarnani, Laura De Padua, Catello Califano, Felicetto Ferrara & Nicola Cascavilla. (2010) Chronic lymphocytic leukemia‐associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients. European Journal of Haematology 85:6, pages 502-507.
Crossref
Francisco Javier Peñalver, Alberto Alvarez-Larrán, Jose Luis Díez-Martin, Laura Gallur, Isidro Jarque, Dolores Caballero, Joaquín Díaz-Mediavilla, Rosalía Bustelos, María Jesús Fernández-Aceñero & José Rafael Cabrera. (2010) Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. Annals of Hematology 89:11, pages 1073-1080.
Crossref
Aamer Aleem, Ahmed S. Alaskar, Farja Algahtani, Mushtaq Rather, Muhamad Hitham Almahayni & Abdulkarim Al-Momen. (2010) Rituximab in immune thrombocytopenia: transient responses, low rate of sustained remissions and poor response to further therapy in refractory patients. International Journal of Hematology 92:2, pages 283-288.
Crossref
David SaadounMathieu Resche RigonDamien SeneBenjamin TerrierAlexandre KarrasLaurent PerardYoland SchoindreBrigitte CoppéréFrançois Blanc, Lucile Musset, Jean-Charles PietteMichele RosenzwajgPatrice Cacoub. (2010) Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C–related mixed cryoglobulinemia. Blood 116:3, pages 326-334.
Crossref
Melca M.O. Barros, Morris A. Blajchman & José O. Bordin. (2010) Warm Autoimmune Hemolytic Anemia: Recent Progress in Understanding the Immunobiology and the Treatment. Transfusion Medicine Reviews 24:3, pages 195-210.
Crossref
Lukáš Smolej, David Belada, Melanie Cermanová, Vladimír Maisnar & Eva Luňáková. (2010) Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: Successful treatment with rituximab. Leukemia Research 34:5, pages e140-e141.
Crossref
F. Perosa, M. Prete, V. Racanelli & F. Dammacco. (2010) CD20‐depleting therapy in autoimmune diseases: from basic research to the clinic. Journal of Internal Medicine 267:3, pages 260-277.
Crossref
Stephan A Botez & David N Herrmann. (2010) Prolonged Remission of a Demyelinating Neuropathy in a Patient With Lymphoma and Sjögren's Syndrome After Rituximab Therapy. Journal of Clinical Neuromuscular Disease 11:3, pages 127-131.
Crossref
Clive S. Zent & Neil E. Kay. (2010) Autoimmune Complications in Chronic Lymphocytic Leukaemia (CLL). Best Practice & Research Clinical Haematology 23:1, pages 47-59.
Crossref
Carlo Visco & Francesco Rodeghiero. (2009) Immune Thrombocytopenia in Lymphoproliferative Disorders. Hematology/Oncology Clinics of North America 23:6, pages 1261-1274.
Crossref
D. Dierickx, G. Verhoef, A. Van Hoof, P. Mineur, A. Roest, A. Triffet, A. Kentos, P. Pierre, D. Boulet, G. Bries, P-Q Lê, A. Janssens & A. Delannoy. (2009) Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. Journal of Internal Medicine 266:5, pages 484-491.
Crossref
Howard A. Liebman. (2009) Recognizing and Treating Secondary Immune Thrombocytopenic Purpura Associated With Lymphoproliferative Disorders. Seminars in Hematology 46, pages S33-S36.
Crossref
M. Michel. (2009) Anémies hémolytiques auto-immunes. EMC - Hématologie 4:2, pages 1-10.
Crossref
Anders Österborg, Claes Karlsson & Jeanette Lundin. (2008) Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia. Current Hematologic Malignancy Reports 4:1, pages 47-53.
Crossref
Elizabeth A. Eklund. 2009. Coagulation in Cancer. Coagulation in Cancer 279 293 .
Dennis Carney & John Seymour. 2008. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 231 260 .
Patrice Cacoub & David Saadoun. (2008) Hepatitis C Virus Infection Induced Vasculitis. Clinical Reviews in Allergy & Immunology 35:1-2, pages 30-39.
Crossref
Aamer Aleem. (2008) Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia. Annals of Saudi Medicine 28:5, pages 382-385.
Crossref
Massimo Gentile, Eugenio Lucia, Caterina Iorio, Ernesto Vigna, Carla Mazzone, Rosellina Morelli, Maria Grazia Bisconte, Carlo Gentile & Fortunato Morabito. (2007) Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient. Cancer Chemotherapy and Pharmacology 62:4, pages 741-743.
Crossref
Michael HallekBruce D. ChesonDaniel CatovskyFederico Caligaris-CappioGuillaume DighieroHartmut DöhnerPeter HillmenMichael J. KeatingEmili MontserratKanti R. Rai & Thomas J. Kipps. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines. Blood 111:12, pages 5446-5456.
Crossref
David Saadoun, Michelle Rosenzwajg, Dan Landau, Jean Charles Piette, David Klatzmann & Patrice Cacoub. (2008) Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis. Blood 111:11, pages 5334-5341.
Crossref
Thein H. Oo. (2008) Rituximab Can Induce a Durable Response in Refractory Immune Thrombocytopenic Purpura Associated with Chronic Lymphocytic Leukemia: Case Report and Review of the Literature. Clinical Leukemia 2:2, pages 140-142.
Crossref
Bernadette Garvey. (2008) Rituximab in the treatment of autoimmune haematological disorders. British Journal of Haematology 141:2, pages 149-169.
Crossref
Carlo ViscoMarco RuggeriMaria Laura Evangelista, Roberto Stasi, Roberta Zanotti, Ilaria GiarettaAchille Ambrosetti, Domenico MadeoGiovanni Pizzolo & Francesco Rodeghiero. (2008) Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia. Blood 111:3, pages 1110-1116.
Crossref
Laurent Sailler. (2007) Rituximab Off Label Use for Difficult-To-Treat Auto-Immune Diseases: Reappraisal of Benefits and Risks. Clinical Reviews in Allergy & Immunology 34:1, pages 103-110.
Crossref
David Saadoun, Aurelien Delluc, Jean Charles Piette & Patrice Cacoub. (2008) Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis. Current Opinion in Rheumatology 20:1, pages 23-28.
Crossref
Moshe E. Gatt, Dina Ben-Yehuda & Shai Izraeli. 2008. Clinical Immunology. Clinical Immunology 1131 1149 .
M. R. Nowrousian. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology 117 148 .
Gary Hoffman, Leonard Calabrese & Carol Langford. 2007. Contemporary Targeted Therapies in Rheumatology. Contemporary Targeted Therapies in Rheumatology 449 466 .
Christof Schweizer, Frederic J. Reu, Anthony D. Ho & Manfred Hensel. (2007) Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Annals of Hematology 86:10, pages 711-717.
Crossref
Briuglia Silvana, La Mazza Antonella, Piraino Basilia, Domenico Trombetta, Antonella Saija & Carmelo Salpietro. (2007) Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome. Pediatric Transplantation 11:5, pages 552-556.
Crossref
Giovanni D?Arena, Catello Califano, Mario Annunziata, Alfredo Tartarone, Silvana Capalbo, Oreste Villani, Giovanni Amendola, Giuseppe Pietrantuono, Felicetto Ferrara, Antonio Pinto, Pellegrino Musto, Alfonso Maria D?Arco & Nicola Cascavilla. (2007) Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients. European Journal of Haematology 79:1, pages 53-58.
Crossref
James B. Bussel, Lisa Giulino, Susan Lee, Vivek L. Patel, Christy Sandborg & E. Richard Stiehm. (2007) Update on Therapeutic Monoclonal Antibodies. Current Problems in Pediatric and Adolescent Health Care 37:4, pages 118-135.
Crossref
Gautam Borthakur, Susan O'Brien, William G. Wierda, Deborah A. Thomas, Jorge E. Cortes, Francis J. Giles, Hagop M. Kantarjian, Susan Lerner & Michael J. Keating. (2007) Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab ? incidence and predictors. British Journal of Haematology 136:6, pages 800-805.
Crossref
M. Leithäuser & M. Freund. 2007. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie 342 384 .
David Saadoun, Mathieu Resche-Rigon, Vincent Thibault, Jean-Charles Piette & Patrice Cacoub. (2006) Antiviral therapy for hepatitis C virus–associated mixed cryoglobulinemia vasculitis: A long-term followup study. Arthritis & Rheumatism 54:11, pages 3696-3706.
Crossref
Karen W.L. Yee & Susan M. O'Brien. (2006) Chronic Lymphocytic Leukemia: Diagnosis and Treatment. Mayo Clinic Proceedings 81:8, pages 1105-1129.
Crossref
Gülsüm Emel Pamuk, Burhan Turgut, Muzaffer Demir, Fatma Tezcan & Özden Vural. (2006) The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia. American Journal of Hematology 81:8, pages 631-633.
Crossref
Giovanni D'Arena, Luca Laurenti, Silvana Capalbo, Alfonso Maria D'Arco, Rosaria De Filippi, Gianpaolo Marcacci, Nicola Di Renzo, Sergio Storti, Catello Califano, Maria Luigia Vigliotti, Michela Tarnani, Felicetto Ferrara & Antonio Pinto. (2006) Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. American Journal of Hematology 81:8, pages 598-602.
Crossref
Kalyani Narra, Hossein Borghaei, Tahseen Al-Saleem, Martin Höglund & Mitchell R. Smith. (2006) Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: Report of two cases and review of the literature. Leukemia Research 30:1, pages 109-114.
Crossref
S. Lehembre, A. Macario-Barrel, P. Musette, P. Carvalho & P. Joly. (2006) Traitement par rituximab d’un purpura thrombopénique immunologique au cours d’un lupus systémique. Annales de Dermatologie et de Vénéréologie 133:1, pages 53-55.
Crossref
Thein H. Oo. (2005) Rituximab is Effective in the Treatment of Refractory Immune Thrombocytopenic Purpura Associated with Chronic Lymphocytic Leukemia. Southern Medical Journal 98:12, pages 1227-1228.
Crossref
Patrice Cacoub, David Saadoun, Nicolas Limal, Jean Marc Léger & Thierry Maisonobe. (2005) Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS 19:Suppl 3, pages S128-S134.
Crossref
Jing Wang & Xuejun Zhu. (2004) The role of pathogenic B-cell clones in antibody mediated autoimmune disorders. Journal of Dermatological Science 36:3, pages 141-148.
Crossref
J. P. Quinn, O. M. Gilligan & M. Horgan. (2004) Evan's syndrome complicating multicentric Castleman's disease - dramatic response to rituximab. European Journal of Haematology 73:5, pages 384-385.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.